Phase II study of cetuximab in combination with carboplatin in patients with relapsed platinum-sensitive ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study
Publication
, Conference
Secord, AA; Blessing, JA; Armstrong, D; Barnes, MN; Lewandowski, G; Mannel, RS
Published in: GYNECOLOGIC ONCOLOGY
March 1, 2007
Duke Scholars
Published In
GYNECOLOGIC ONCOLOGY
ISSN
0090-8258
Publication Date
March 1, 2007
Volume
104
Issue
3
Start / End Page
S32 / S32
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Secord, A. A., Blessing, J. A., Armstrong, D., Barnes, M. N., Lewandowski, G., & Mannel, R. S. (2007). Phase II study of cetuximab in combination with carboplatin in patients with relapsed platinum-sensitive ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study. In GYNECOLOGIC ONCOLOGY (Vol. 104, pp. S32–S32). ACADEMIC PRESS INC ELSEVIER SCIENCE.
Secord, Angeles Alvarez, John A. Blessing, Deborah Armstrong, Mack N. Barnes, George Lewandowski, and Robert S. Mannel. “Phase II study of cetuximab in combination with carboplatin in patients with relapsed platinum-sensitive ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study.” In GYNECOLOGIC ONCOLOGY, 104:S32–S32. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2007.
Secord AA, Blessing JA, Armstrong D, Barnes MN, Lewandowski G, Mannel RS. Phase II study of cetuximab in combination with carboplatin in patients with relapsed platinum-sensitive ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study. In: GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2007. p. S32–S32.
Secord, Angeles Alvarez, et al. “Phase II study of cetuximab in combination with carboplatin in patients with relapsed platinum-sensitive ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study.” GYNECOLOGIC ONCOLOGY, vol. 104, no. 3, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2007, pp. S32–S32.
Secord AA, Blessing JA, Armstrong D, Barnes MN, Lewandowski G, Mannel RS. Phase II study of cetuximab in combination with carboplatin in patients with relapsed platinum-sensitive ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2007. p. S32–S32.
Published In
GYNECOLOGIC ONCOLOGY
ISSN
0090-8258
Publication Date
March 1, 2007
Volume
104
Issue
3
Start / End Page
S32 / S32
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis